BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24721786)

  • 1. Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.
    Chen PC; Cheng HC; Wang J; Wang SW; Tai HC; Lin CW; Tang CH
    Oncotarget; 2014 Mar; 5(6):1595-608. PubMed ID: 24721786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway.
    Chen PC; Cheng HC; Tang CH
    Carcinogenesis; 2013 Jul; 34(7):1669-79. PubMed ID: 23536580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
    Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
    J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells.
    Chen PC; Lin TH; Cheng HC; Tang CH
    Carcinogenesis; 2012 Apr; 33(4):937-45. PubMed ID: 22345292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.
    Pang X; Zhang L; Lai L; Chen J; Wu Y; Yi Z; Zhang J; Qu W; Aggarwal BB; Liu M
    Carcinogenesis; 2011 Jun; 32(6):904-12. PubMed ID: 21427164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.
    Guo Z; Xing Z; Cheng X; Fang Z; Jiang C; Su J; Zhou Z; Xu Z; Holmberg A; Nilsson S; Liu Z
    PLoS One; 2015; 10(5):e0124292. PubMed ID: 26010447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.
    Kono Y; Kawakami S; Higuchi Y; Yamashita F; Hashida M
    Biol Pharm Bull; 2014; 37(1):137-44. PubMed ID: 24141263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.
    Jia Q; Xue T; Zhang Q; Cheng W; Zhang C; Ma J; Bu Y; Yu S; Liu Q
    Sci Rep; 2017 Oct; 7(1):13846. PubMed ID: 29061995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
    Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
    Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The M2 macrophages induce autophagic vascular disorder and promote mouse sensitivity to urethane-related lung carcinogenesis.
    Li GG; Guo ZZ; Ma XF; Cao N; Geng SN; Zheng YQ; Meng MJ; Lin HH; Han G; Du GJ
    Dev Comp Immunol; 2016 Jun; 59():89-98. PubMed ID: 26806760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.
    Kumar A; Sunita P; Jha S; Pattanayak SP
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):939-50. PubMed ID: 27297262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
    Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
    Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.
    Liu L; Ge D; Ma L; Mei J; Liu S; Zhang Q; Ren F; Liao H; Pu Q; Wang T; You Z
    J Thorac Oncol; 2012 Jul; 7(7):1091-100. PubMed ID: 22534817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.
    Shimoyama T; Hiraoka S; Takemoto M; Koshizaka M; Tokuyama H; Tokuyama T; Watanabe A; Fujimoto M; Kawamura H; Sato S; Tsurutani Y; Saito Y; Perbal B; Koseki H; Yokote K
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):675-82. PubMed ID: 20139355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
    Chetty C; Lakka SS; Bhoopathi P; Kunigal S; Geiss R; Rao JS
    Cancer Res; 2008 Jun; 68(12):4736-45. PubMed ID: 18559520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.